Pizzuti Dana
Chief Med and Dev Officer
Pizzuti Dana has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 3, 2025.
On the most recent filing, Pizzuti Dana is listed as Chief Med and Dev Officer at Crinetics Pharmaceuticals, Inc. Inside the rolling window, Pizzuti Dana reported no open-market purchases and 2 open-market sales totaling $438K in CRNX. The largest disclosed transaction in the window is a sale of 5,000 CRNX shares on Dec 1, 2025, worth $225K.
Companies traded
Other insiders at CRNX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$438K
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Pizzuti Dana made?
Pizzuti Dana has filed 4 SEC Form 4 filings (9 transaction rows) across 1 company since 2025.
Which companies does Pizzuti Dana trade?
Pizzuti Dana has filed SEC Form 4 disclosures for 1 company, including CRNX.
When was Pizzuti Dana's most recent SEC Form 4 filing?
Pizzuti Dana's most recent SEC Form 4 filing on Tracefour is dated Dec 3, 2025.
What is Pizzuti Dana's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pizzuti Dana is listed as Chief Med and Dev Officer.
What is Pizzuti Dana's total buy and sell value in the current window?
Inside the rolling retention window, Pizzuti Dana bought $0 and sold $438K based on SEC Form 4 filings.
What was Pizzuti Dana's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,000 CRNX shares on 2025-12-01, worth $225K, per SEC Form 4 filings.